异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼股价盘前大涨12%

异动解读11-06

医疗器械公司Globus Medical Inc.(纽约证券交易所代码:GMED)期周一股价盘前大涨12.46%,主因其第三季度业绩和全年预期均超出市场预期。

财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。

公司称,第三季度业绩出色主要得益于近期收购医疗器械公司NuVasive。公司旗下的脊柱产品销售和使能技术产品及服务销量的强劲表现也为业绩增长贡献重要力量,尤其是在国际市场,净销售额同比增长达74.8%。

凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前指引2.80-2.90美元,也超过了华尔街2.85美元的共识预期。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1135819053?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-06 17:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135819053","market":"hk","top_or_hot":-1,"title":"异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%","media":"异动解读","content":"<p>医疗器械公司Globus Medical Inc.(纽约证券交易所代码:GMED)期周一股价盘前大涨12.46%,主因其第三季度业绩和全年预期均超出市场预期。</p>\n\n<p>财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。</p>\n\n<p>公司称,第三季度业绩出色主要得益于近期收购医疗器械公司NuVasive。公司旗下的脊柱产品销售和使能技术产品及服务销量的强劲表现也为业绩增长贡献重要力量,尤其是在国际市场,净销售额同比增长达74.8%。</p>\n\n<p>凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前指引2.80-2.90美元,也超过了华尔街2.85美元的共识预期。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-06 17:48 北京时间&nbsp;&nbsp;&nbsp;<strong>异动解读</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>医疗器械公司Globus Medical Inc.(纽约证券交易所代码:GMED)期周一股价盘前大涨12.46%,主因其第三季度业绩和全年预期均超出市场预期。\n财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。\n公司称,第三季度业绩出色主要得益于...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GMED","symbol_name":"Globus Medical Inc","start_time":0,"source_url":"","article_id":"1135819053","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135819053","pubTimestamp":1730886505,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"医疗器械公司Globus Medical Inc.期周一股价盘前大涨12.46%,主因其第三季度业绩和全年预期均超出市场预期。财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。公司称,第三季度业绩出色主要得益于近期收购医疗器械公司NuVasive。凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前指引2.80-2.90美元,也超过了华尔街2.85美元的共识预期。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"GMED":"Globus Medical Inc"},"translate_title":"Interpretation of changes: Orthopedic medical device manufacturer Globus Medical's third-quarter results were impressive, and its stock price rose 12% before the market opened.","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GMED":1},"content_text":"医疗器械公司Globus Medical Inc.(纽约证券交易所代码:GMED)期周一股价盘前大涨12.46%,主因其第三季度业绩和全年预期均超出市场预期。\n财报显示,Globus Medical第三季度调整后每股收益为0.83美元,高于分析师预期的0.65美元。公司第三季度收入达到6.257亿美元,同比增长63.1%,也超过了分析师预测的6.0471亿美元。\n公司称,第三季度业绩出色主要得益于近期收购医疗器械公司NuVasive。公司旗下的脊柱产品销售和使能技术产品及服务销量的强劲表现也为业绩增长贡献重要力量,尤其是在国际市场,净销售额同比增长达74.8%。\n凭借第三季度的出色表现,Globus Medical上调了2024财年的每股收益指引至2.90-3.00美元,高于此前指引2.80-2.90美元,也超过了华尔街2.85美元的共识预期。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1135819053"}

异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼 股价盘前大涨12%

精彩评论

异动解读 | 骨科医疗器械商Globus Medical第三季度业绩亮眼股价盘前大涨12%